ArtBlood
PrivateLast Round
Series B
Nov 1, 2025
Total Funding Raised
$20.84M
Company Overview
ArtBlood is a biotechnology company that develops a cell-based in vitro blood production system intended to solve the problem of blood transfusion shortages.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArtBlood Comparables
Compare ArtBlood with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RedC Biotech | 81% | |
| Scarlet Therapeutics | 77% | |
| Megakaryon Corporation | 75% |
ArtBlood Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 1, 2025 | ||||
| Series A | Sep 24, 2024 | ||||
| Series A | Apr 9, 2024 | ||||
| Grant | Aug 1, 2023 | ||||
| Seed | Jul 1, 2022 |
ArtBlood Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Accelerator | Series A |
| Korea Investment Accelerator | Series A |
| Heungkuk Securities | Series A |
| Korea Development Bank | Series A |
| Ministry of Health and Welfare (South Korea) | Grant |
| Partners Investment | Series A |
| SERIES Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2024
$8M round led by Heungkuk Securities and Partners Investment.
- Aug 1, 2023
Secured $3.46M from the Ministry of Health and Welfare.
ArtBlood Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ArtBlood's valuation, stock price, and market status.
Is ArtBlood a public or private company?
ArtBlood is a private company.
What is the current stock price of ArtBlood?
ArtBlood is a private company with no public stock price. No recent secondary market data is available.
How much is ArtBlood worth (valuation)?
Valuation information for ArtBlood is not publicly available.
Can I buy ArtBlood stock?
ArtBlood shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ArtBlood's last funding round?
ArtBlood's most recent funding round was Series A on April 9, 2024.
Who are the main investors in ArtBlood?
Key investors in ArtBlood include Korea Investment Accelerator, Heungkuk Securities, Korea Development Bank, Partners Investment.
Will ArtBlood IPO soon?
No public IPO plans have been announced for ArtBlood.
How can I track ArtBlood secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ArtBlood's secondary market activity and sign up for updates.